By creating artificial aging in mice, researchers at Lund University in Sweden have been able to track the formation of ...

PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

The Cardiac Centre at Al Qassimi Hospital, operated by Emirates Health Services (EHS), has become the first facility in the ...

Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

Panelists discuss how managing patients with comorbidities requires careful evaluation to distinguish true Group 1 PAH features from underlying cardiac or pulmonary disease, with a more measured ...

The projection represents a negative annual growth rate of 0.08%. The total number of diagnosed prevalent cases of pulmonary ...

Pulmonary hypertension is a rare, ostensibly incurable, and etiologically diverse disease with an unacceptably high 5-year mortality rate (≈50%), worse than many cancers. Irrespective of pathogenic ...

Pulmonary arterial hypertension (PAH) is a rare but lethal disorder caused by several pathological changes in the pulmonary vasculature. There is endothelial cell dysfunction characterized by ...

EP: 1. Pathophysiology of Pulmonary Arterial Hypertension EP: 2. Differential Diagnosis of Pulmonary Arterial Hypertension EP: 3. Importance of Early Detection and Monitoring for Disease ...

Group 4: CTEPH (chronic thromboembolic pulmonary hypertension)—In some patients, pulmonary embolism, or blood clots, in the lung’s arteries can form scar-like tissue, blocking or narrowing the ...

If you are diagnosed with pulmonary hypertension (PH) or your doctor suspects PH, it is important for you to see a specialist. Pulmonary arterial hypertension (PAH) is a rare, progressive lung disease ...

BMPER overexpression mitigated the vascular remodeling that characterizes pulmonary arterial hypertension (PAH), according to a preclinical study published in Cellular Signalling. In vivo and in ...